ASIC1a, a new therapeutic drug target for cardiac ischemia [ 1/1/2021 - 12/31/2024 ]

Research Grant

Brief description Cardiovascular disease is the biggest killer in the world, in large part due to the lack of drugs to protect the heart from the damage caused by injuries such as heart attack. Our team of world-leading scientists and clinicians has identified a novel therapeutic target (ASIC1a) against which drugs could be targeted to protect the heart against these injuries. The aim of this project is to develop novel cardioprotective drugs that target ASIC1a so we can test them in human clinical trials.

Funding Amount $1,382,224

Funding Scheme Ideas Grants

Chief Investigator Dr Nathan Palpant

Notes Ideas Grants